Matsushita T - Search Results

1

Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells.

Mizumaki K, Horii M, Kano M, Komuro A, Matsushita T. Mizumaki K, et al. Among authors: matsushita t. Sci Rep. 2021 Jan 22;11(1):2106. doi: 10.1038/s41598-021-81588-8. Sci Rep. 2021. PMID: 33483537 Free PMC article.

2

Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.

Le Huu D, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Tedder TF, Fujimoto M. Le Huu D, et al. Among authors: matsushita t. Blood. 2013 Apr 18;121(16):3274-83. doi: 10.1182/blood-2012-11-465658. Epub 2013 Feb 19. Blood. 2013. PMID: 23422748 Free article.

3

B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells.

Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, Naka K, Hirao A, Takehara K, Fujimoto M. Jin G, et al. Among authors: matsushita t. J Allergy Clin Immunol. 2013 Jun;131(6):1674-82. doi: 10.1016/j.jaci.2013.01.044. Epub 2013 Mar 25. J Allergy Clin Immunol. 2013. PMID: 23534976

4

Regulatory B cells in mouse models of systemic lupus erythematosus (SLE).

Matsushita T. Matsushita T. Methods Mol Biol. 2014;1190:195-205. doi: 10.1007/978-1-4939-1161-5_14. Methods Mol Biol. 2014. PMID: 25015282

5

Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity.

Matsushita T, Hamaguchi Y, Hasegawa M, Takehara K, Fujimoto M. Matsushita T, et al. Rheumatology (Oxford). 2016 Feb;55(2):263-7. doi: 10.1093/rheumatology/kev331. Epub 2015 Sep 8. Rheumatology (Oxford). 2016. PMID: 26350483

6

Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.

Matsushita T, Mizumaki K, Kano M, Yagi N, Tennichi M, Takeuchi A, Okamoto Y, Hamaguchi Y, Murakami A, Hasegawa M, Kuwana M, Fujimoto M, Takehara K. Matsushita T, et al. Br J Dermatol. 2017 Feb;176(2):395-402. doi: 10.1111/bjd.14882. Epub 2017 Jan 19. Br J Dermatol. 2017. PMID: 27452897

7

Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease.

Matsushita T, Date M, Kano M, Mizumaki K, Tennichi M, Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K. Matsushita T, et al. Am J Pathol. 2017 Apr;187(4):841-850. doi: 10.1016/j.ajpath.2016.12.016. Epub 2017 Feb 9. Am J Pathol. 2017. PMID: 28189565 Free article.

8

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.

Matsushita T, Kobayashi T, Mizumaki K, Kano M, Sawada T, Tennichi M, Okamura A, Hamaguchi Y, Iwakura Y, Hasegawa M, Fujimoto M, Takehara K. Matsushita T, et al. Sci Adv. 2018 Jul 11;4(7):eaas9944. doi: 10.1126/sciadv.aas9944. eCollection 2018 Jul. Sci Adv. 2018. PMID: 30009261 Free PMC article.

9

Regulatory and effector B cells: Friends or foes?

Matsushita T. Matsushita T. J Dermatol Sci. 2019 Jan;93(1):2-7. doi: 10.1016/j.jdermsci.2018.11.008. Epub 2018 Nov 23. J Dermatol Sci. 2019. PMID: 30514664 Free article. Review.

10

Attenuation of murine sclerodermatous models by the selective S1P₁ receptor modulator cenerimod.

Kano M, Kobayashi T, Date M, Tennichi M, Hamaguchi Y, Strasser DS, Takehara K, Matsushita T. Kano M, et al. Among authors: matsushita t. Sci Rep. 2019 Jan 24;9(1):658. doi: 10.1038/s41598-018-37074-9. Sci Rep. 2019. PMID: 30679645 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,271 results

Search Page

Filters